ArticleMethods in enzymology2022

Nanoluciferase-based cell fusion assay for rapid and high-throughput assessment of SARS-CoV-2-neutralizing antibodies in patient samples.

Max Meyrath et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.